Serum antibodies against brain tissue in multiple sclerosis patients: a frequent phenomenon in chronic progressive, but not relapsing disease course
Henneberg, A.; Mayle, D.M.; Pfau, J.U.; Hartmann, P.; Elsner, U.; Kornhuber, H.H.
Zeitschrift für Arztliche Fortbildung 88(7-8): 593-596
1994
ISSN/ISBN: 0044-2178 PMID: 7856267 Document Number: 426662
Document emailed within 1 workday
Related Documents
Bergamaschi, R.; Versino, M.; Raiola, E.; Citterio, A.; Cosi, V. 1993: High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. one year follow-up Acta Neurologica 15(1): 33-43Bilińska, M.łg.; Frydecka, I.; Kosmaczewska, A.; Ciszak, L.; Koszewicz, M.; Pokryszko-Dragan, A. 2006: CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(115): 41-45
Feys, P.; Bibby, B.M.; Baert, I.; Dalgas, U. 2015: Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis European Journal of Physical and Rehabilitation Medicine 51(2): 207-210
Wender, M.; Michałowska, G. 1986: IgG synthesis in the cerebrospinal fluid in patients with the chronic progressive phase of multiple sclerosis treated with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 20(6): 536-541
Totolian, N.A.; Luchakova, O.S. 1996: Antibodies to brain galactocerebrosides in the serum and cerebrospinal fluid of patients with disseminated sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 96(4): 75-77
Musaeva, L. S.; Gannyshkina, I.V.; Zavalishin, I.A.; Markova, E.D.; Ivanova-Smolenskaia, I.A. 2002: Regularities of fixation of brain serum antibodies from patients with lateral amyotrophic sclerosis in rabbit CNS Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 10-14
Shanina, N.A.; Sveĭkata, A.P.; Zavalishin, I.A.; Gel'fand, V.I. 1993: Analysis of serum antibodies to nerve tissue antigens in patients with lateral amyotrophic sclerosis Biulleten' Eksperimental'noi Biologii i Meditsiny 115(2): 169-173
Zaprianova, E.; Deleva, D.; Bakalska, M.; Filchev, N. 1997: Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis Morfologiia 112(6): 25-28
Morrow, T. 2013: Relapsing multiple sclerosis patients can look to second oral agent Managed Care 22(2): 51-52
Losy, J.; Niezgoda, A.; Zaremba, J.ła. 2002: IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis Folia Neuropathologica 40(3): 151-153
Hauser, S.L.; Fosburg, M.; Kevy, S.V.; Weiner, H.L. 1984: Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects Neurology 34(7): 922-926
Watanabe, T.; Yamamoto, T.; Saito, T.; Sugano, M.; Tsukamoto, T. 1993: Pulse-dose cyclophosphamide therapy for chronic progressive multiple sclerosis Rinsho Shinkeigaku 33(1): 15-20
Pokryszko-Dragan, A.; Bilińska, M.łg.; Gruszka, E.; Dubik-Jezierzańska, M. 2005: Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(113): 654-658
Pietropaolo, V.; Fioriti, D.; Mischitelli, M.; Anzivino, E.; Santini, M.; Millefiorini, E.; Di Rezze, S.; Degener, A.Marta. 2005: Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis New Microbiologica 28(3): 199-203
Baronica, K.B.ć; Mlinac, K.; Ozretić, D.; Vladić, A.; Bognar, S.K. 2011: Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression Collegium Antropologicum 35(Suppl 1): 11-16
Stelmasiak, Z.; Bartosik-Psujek, H.; Belniak-Legieć, E.; Mitosek-Szewczyk, K. 2000: The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS) Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 55: 221-225
Cabrera-Gómez, J.A.; Echazábal-Santana, N.; Porrero-Martín, P.; Valenzuela-Silva, C.; Rodríguez, C.A.; Fuentes-Suárez, I.; Pérez-Ruiz, L.; Ramos-Cedeño, A.M.; Cabrera-Núñez, J.A. 2003: Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis Revista de Neurologia 37(3): 214-220
Kastrukoff, L.F.; Oger, J.J.; Tourtellotte, W.W.; Sacks, S.L.; Berkowitz, J.; Paty, D.W. 1991: Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation Neurology 41(12): 1936-1941
Wender, M.; Tokarz-Kupczyk, E.; Mularek, O. 1989: Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression Neurologia i Neurochirurgia Polska 23(3): 188-192
Wender, M.; Tokarz-Kupczyk, E.; Mularek, O. 1988: Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 22(5): 399-403